EP 32 – Snehal Patel – CEO at MyDoc – Less Disruption, More Cooperation


Michael has previously worked for major international organisations including Morgan Stanley, Goldman Sachs, UBS and CitiGroup as well as supported and advised local tech giants like aCommerce and investors like Ardent Capital in Thailand. Since 2016, Michael has been running his media business hosting several tech podcasts in Asia.

Snehal Patel

Dr. Patel is the CEO and co-founder of MyDoc. Previously, he was a Senior Vice President at Clermont Group, a multi-billion dollar investment fund based in Singapore. In this role, he founded and led the investment team responsible for investing in healthcare businesses in South and Southeast Asia. Prior to moving to Singapore in 2008, Dr. Patel practiced law at Cravath in New York. He received an MD from the Columbia University College of Physicians and Surgeons and a JD from Columbia Law School. Upon graduation, he served as a Clinical Fellow at the Harvard Medical School.

This episode is brought to you by:

In this episode, Michael Waitze talked to Dr. Snehal Patel, Co-Founder & CEO of MyDoc. The Singaporean B2B HealthTech company has built a comprehensive healthcare services network across Asia that connects organizations, governments, and patients to doctors, pharmacies, insurers, and laboratories. MyDoc’s goal is to create an efficient and effective healthcare ecosystem for patients and doctors. Their services include Digital Concierge, Electronic Personal Health Screenings and Virtual Clinics. 

Dr. Snehal talks about value-based care and how insurers are more focused on customer engagement and prevention today. He gives insight into quantifiable healthcare and the development of IoT devices that help track health indicators, such as glucose levels, for example. With the use of AI and machine learning, new data points can be used to give better insight into health status on a population level and can lead to improved diagnostic outcomes. 

Dr. Snehal also discusses the increase of people with chronic diseases like diabetes and hypertension and how telemedicine can help to keep costs down. However, he also stresses that telemedicine by itself is not that powerful. It needs to be part of a holistic end-to-end value proposition.

Related Podcasts

Episode 37